Valeant Pharmaceuticals International, Inc. Company Profile

Aggregated data from the web about Valeant Pharmaceuticals International, Inc.

Company Name	Valeant Pharmaceuticals International, Inc.
Website	https://morgantico.com
Snippet	Valeant Pharmaceuticals International, Inc. (TSX: VRX, NYSE: VRX, FRA: BVF, BMV: VRXN, SIX: VRX) Superior Court of Quebec, Court File No.: 500-06-000783-136 Settlement with Valeant:On November 16, 2020, the settlement between the plaintiffs and Valeant Pharmaceuticals International Inc. (now Bausch Health Companies Inc). et al. was approved without any admission of liability on the part...
Type	Public
Founded	1959
Founder	Milan Panić
Revenue	US$8.601 billion (2019)[1]
Website	www.bauschhealth.com
Industry	Pharmaceuticals
Traded as	TSX: BHCNYSE: BHCS&P/TSX 60 component
Key people	Joseph C. Papa(Chairman & CEO)Paul S. Herendeen(Executive VP & CFO)Sam Eldessouky(Senior VP & Controller)
Net income	US$−1.788 billion (2019)[1]
Headquarters	Laval, Quebec, CanadaBridgewater, New Jersey, US
Subsidiaries	Bausch & LombSalix PharmaceuticalsMedicis PharmaceuticalSolta MedicalOraPharma
Total assets	US$33.863 billion (2019)[1]
Total equity	US$1.063 billion (2019)[1]
Operating income	US$−0.203 billion (2019)[1]
Number of employees	~21,100 (December 2018)[1]

Valeant Pharmaceuticals International, Inc. is part of the Canada company list

Valeant Pharmaceuticals International, Inc. is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.